国药一致2025年净利预计10.55亿元至12.15亿元

Core Viewpoint - China National Pharmaceutical Group Corporation (国药一致) forecasts a net profit attributable to shareholders of 1.055 billion to 1.215 billion yuan for 2025, representing a year-on-year growth of 64.2% to 89.11% [1] Group 1 - The company aims to continue its strategic transformation and refined management to further consolidate operational results [1] - The focus is on enhancing core competitiveness and achieving sustainable, high-quality development [1]